Antibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- V2177 - Provider product page
- Provider
- NSJ Bioreagents
- Product name
- Cytokeratin 18 Antibody
- Antibody type
- Monoclonal
- Antigen
- PMC-42 human breast carcinoma cells were used as the immunogen for this Cytokeratin 18 antibody.
- Description
- Protein G purified antibody
- Reactivity
- Human, Rat, Bovine, Canine, Hamster, Porcine, Sheep
- Host
- Mouse
- Conjugate
- Unconjugated
- Antibody clone number
- DC10
- Vial size
- 20 µg, 100 µg (with sodium azide), 100 µg (without sodium azide), 7 ml (prediluted for IHC use, if applicable)
- Storage
- Store the Cytokeratin 18 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
Submitted references Apocrine hidrocystoma of the lower lip: a case report and literature review.
IBP regulates epithelial-to-mesenchymal transition and the motility of breast cancer cells via Rac1, RhoA and Cdc42 signaling pathways.
Evaluation of the diagnostic value of serum and tissue apoptotic cytokeratin-18 in patients with chronic hepatitis C.
Immunoreactivity for calretinin and keratins in desmoid fibromatosis and other myofibroblastic tumors: a diagnostic pitfall.
Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines.
Persistent Chlamydia trachomatis infection of HeLa cells mediates apoptosis resistance through a Chlamydia protease-like activity factor-independent mechanism and induces high mobility group box 1 release.
Keratin hypersumoylation alters filament dynamics and is a marker for human liver disease and keratin mutation.
Nonclassical major histocompatibility complex I-like Fc neonatal receptor (FcRn) expression in neonatal human tissues.
Kikuchi K, Fukunaga S, Inoue H, Miyazaki Y, Ide F, Kusama K
Head and neck pathology 2014 Mar;8(1):117-21
Head and neck pathology 2014 Mar;8(1):117-21
IBP regulates epithelial-to-mesenchymal transition and the motility of breast cancer cells via Rac1, RhoA and Cdc42 signaling pathways.
Zhang Z, Yang M, Chen R, Su W, Li P, Chen S, Chen Z, Chen A, Li S, Hu C
Oncogene 2014 Jun 26;33(26):3374-82
Oncogene 2014 Jun 26;33(26):3374-82
Evaluation of the diagnostic value of serum and tissue apoptotic cytokeratin-18 in patients with chronic hepatitis C.
Abdel Haleem H, Zayed N, Abdel Hafez H, Fouad A, Akl M, Hassan M, Hammam O, Morsy A, Saleh A, Seyam M, Zakaria Z, Zakaria S
Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology 2013 Jun;14(2):68-72
Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology 2013 Jun;14(2):68-72
Immunoreactivity for calretinin and keratins in desmoid fibromatosis and other myofibroblastic tumors: a diagnostic pitfall.
Barak S, Wang Z, Miettinen M
The American journal of surgical pathology 2012 Sep;36(9):1404-9
The American journal of surgical pathology 2012 Sep;36(9):1404-9
Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines.
Martowicz A, Spizzo G, Gastl G, Untergasser G
BMC cancer 2012 Oct 30;12:501
BMC cancer 2012 Oct 30;12:501
Persistent Chlamydia trachomatis infection of HeLa cells mediates apoptosis resistance through a Chlamydia protease-like activity factor-independent mechanism and induces high mobility group box 1 release.
Rödel J, Grosse C, Yu H, Wolf K, Otto GP, Liebler-Tenorio E, Forsbach-Birk V, Straube E
Infection and immunity 2012 Jan;80(1):195-205
Infection and immunity 2012 Jan;80(1):195-205
Keratin hypersumoylation alters filament dynamics and is a marker for human liver disease and keratin mutation.
Snider NT, Weerasinghe SV, Iñiguez-Lluhí JA, Herrmann H, Omary MB
The Journal of biological chemistry 2011 Jan 21;286(3):2273-84
The Journal of biological chemistry 2011 Jan 21;286(3):2273-84
Nonclassical major histocompatibility complex I-like Fc neonatal receptor (FcRn) expression in neonatal human tissues.
Cianga C, Cianga P, Plamadeala P, Amalinei C
Human immunology 2011 Dec;72(12):1176-87
Human immunology 2011 Dec;72(12):1176-87
No comments: Submit comment
Supportive validation
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- Western blot testing of human samples using DC10 antibody.
Supportive validation
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- IHC testing of human skin sweat gland stained with DC10 antibody. Note cytoplasmic staining of tumor cells.